https://www.zonebourse.com/cours/action/CSTONE-PHARMACEUTICALS-57946082/actualite/CStone-Pharmaceuticals-presente-les-resultats-de-l-etude-de-phase-3-du-sugemalimab-dans-le-traite-44242571/?utm_source=telegram&utm_medium=social&utm_campaign=share